Therapeutic areas in focus
Therapeutic Areas in Focus
Volume 75 Autumn 2023
Dive into our news section to read the latest updates in the pharma world from Novo Nordisk partnering with UNICEF to reduce childhood obesity (page 8) to results from AstraZeneca and Daiichi Sankyo’s phase 3 trial for datopotamab deruxtecan (page 7).
Read on for all this and much more!
CARDIOVASCULAR AND METABOLIC DISEASES
This issue’s cardiovascular and metabolic diseases section includes some fascinating articles. The first from AstraZeneca considers the rise in non-communicable diseases and what healthcare systems should be doing to combat this (
). Also in this section, Amarin tells Pharmafile about the impacts of COVID-19 on cardiovascular disease (CVD) and the next steps in CVD treatment in the UK (
Our women’s health section provides an overview of the most important areas of the industry. Theramex shares an in-depth overview of women’s health in the UK, assessing the current standard of care, before considering what innovations are taking place to help to improve the field (
). Meanwhile, Medidata explores the need for gender diversity in clinical trials and how this is likely to improve clinical trial outcomes (
The most in-depth section in this issue, our oncology topic covers various areas of the oncology sphere from AI to prostate cancer. Biomap considers the use of AI in immuno-oncology and how it can improve drug discovery (
), KAUST considers the future of targeted oncology drug design and how nuclear magnetic resonance can be used for cancer treatment (
) and Parexel assesses the need for diversity in oncology clinical trials specifically for personalised medicines (
Executive Director – PMGroup Worldwide Ltd -
Group Managing Editor – PMGroup Worldwide Ltd -
Editorial Assistant -
Sales Manager -
Subscriptions & Data Management
Curwood CMS Ltd, Unit 9 Barns & Stables, Timworth Green, IP31 1HS
Tel: 01580 883841
Pharmafile is published each Summer and Autumn.
For subscription information, please contact us.
The opinions and views expressed by contributors in this book are not necessarily those of the Publisher and, while every care has been taken in the preparation of this book, the Publisher is not responsible for such opinion and views, or for any inaccuracies in the contributions and data it contains.
The Publisher is not responsible for any images or graphics supplied by contributors. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means, without prior permission from Samedan Ltd.
ISSN 0959-8758. All rights reserved.© 2023 Samedan Ltd
Cover image: © MaximMorales / Shutterstock
Pharmafile, Samedan Ltd, Suite E, 11 BellYard Mews, 175 Bermondsey Street, London SE1 3TN, United Kingdom
T: +44 (0)20 7724 3456